Genetic Variations in AMPK, FOXO3A, and POMC Increase the Risk of Extreme Obesity.

IF 3.8 Q2 ENDOCRINOLOGY & METABOLISM
Journal of Obesity Pub Date : 2024-10-24 eCollection Date: 2024-01-01 DOI:10.1155/2024/3813621
Cinthia Vila Nova Santana, Luiz Alexandre Viana Magno, Adauto Versiani Ramos, Maria Angélica Rios, Valéria Cristina Sandrim, Luiz Armando De Marco, Débora Marques de Miranda, Marco Aurélio Romano-Silva
{"title":"Genetic Variations in <i>AMPK</i>, <i>FOXO3A</i>, and <i>POMC</i> Increase the Risk of Extreme Obesity.","authors":"Cinthia Vila Nova Santana, Luiz Alexandre Viana Magno, Adauto Versiani Ramos, Maria Angélica Rios, Valéria Cristina Sandrim, Luiz Armando De Marco, Débora Marques de Miranda, Marco Aurélio Romano-Silva","doi":"10.1155/2024/3813621","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> Genetic variability significantly impacts metabolism, weight gain, and feeding behaviors, predisposing individuals to obesity. This study explored how variations in key genes related to obesity-<i>FOXO3A</i> (forkhead box O3), <i>AMPK</i> (protein kinase AMP-activated), and <i>POMC</i> (proopiomelanocortin)-are associated with extreme obesity (EOB). <b>Methods:</b> We conducted a case-control study with 251 EOB patients and 212 healthy controls with a body mass index (BMI) of less than 25 kg/m<sup>2</sup>. We genotyped 10 single nucleotide variants (SNVs) using TaqMan-based assays. <b>Results:</b> Four SNVs-rs1536057 in <i>FOXO3A</i>, rs103685 in <i>AMPK</i>, rs934778, and rs6545975 in <i>POMC</i>-were associated with an increased risk of EOB. The strongest association was observed with rs934778 (<i>POMC</i>), which had a maximum odds ratio (OR) of 5.26 (95% CI: 2.86-9.09). While these genetic variations are closely linked to EOB, they do not affect serum glucose, triglycerides, HDL, LDL, BMI, or waist circumference. <b>Conclusions:</b> These findings indicate that factors beyond traditional metabolic pathways, potentially related to feeding behavior or hormonal regulation, may also link these genetic variations to obesity. Further research in a larger sample is essential to validate these findings and explore their potential to guide clinical interventions and public health strategies.</p>","PeriodicalId":16628,"journal":{"name":"Journal of Obesity","volume":"2024 ","pages":"3813621"},"PeriodicalIF":3.8000,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527528/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Obesity","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2024/3813621","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Genetic variability significantly impacts metabolism, weight gain, and feeding behaviors, predisposing individuals to obesity. This study explored how variations in key genes related to obesity-FOXO3A (forkhead box O3), AMPK (protein kinase AMP-activated), and POMC (proopiomelanocortin)-are associated with extreme obesity (EOB). Methods: We conducted a case-control study with 251 EOB patients and 212 healthy controls with a body mass index (BMI) of less than 25 kg/m2. We genotyped 10 single nucleotide variants (SNVs) using TaqMan-based assays. Results: Four SNVs-rs1536057 in FOXO3A, rs103685 in AMPK, rs934778, and rs6545975 in POMC-were associated with an increased risk of EOB. The strongest association was observed with rs934778 (POMC), which had a maximum odds ratio (OR) of 5.26 (95% CI: 2.86-9.09). While these genetic variations are closely linked to EOB, they do not affect serum glucose, triglycerides, HDL, LDL, BMI, or waist circumference. Conclusions: These findings indicate that factors beyond traditional metabolic pathways, potentially related to feeding behavior or hormonal regulation, may also link these genetic variations to obesity. Further research in a larger sample is essential to validate these findings and explore their potential to guide clinical interventions and public health strategies.

AMPK、FOXO3A 和 POMC 的基因变异会增加极度肥胖的风险。
目的基因变异对新陈代谢、体重增加和进食行为有重大影响,易导致肥胖。本研究探讨了与肥胖有关的关键基因--FOXO3A(叉头盒 O3)、AMPK(蛋白激酶 AMP-活化)和 POMC(原髓皮质素)的变异如何与极度肥胖(EOB)相关。研究方法我们对 251 名 EOB 患者和 212 名体重指数(BMI)低于 25 kg/m2 的健康对照者进行了病例对照研究。我们使用基于 TaqMan 的检测方法对 10 个单核苷酸变异体 (SNV) 进行了基因分型。结果显示FOXO3A 中的四个 SNVs-rs1536057、AMPK 中的 rs103685、rs934778 和 POMC 中的 rs6545975 与 EOB 风险增加有关。其中,rs934778(POMC)的关联性最强,其最大比值比 (OR) 为 5.26(95% CI:2.86-9.09)。虽然这些基因变异与 EOB 密切相关,但它们并不影响血清葡萄糖、甘油三酯、高密度脂蛋白、低密度脂蛋白、体重指数或腰围。结论:这些研究结果表明,传统代谢途径之外的因素(可能与进食行为或激素调节有关)也可能将这些基因变异与肥胖联系在一起。要验证这些发现并探索其指导临床干预和公共卫生策略的潜力,必须在更大样本中开展进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Obesity
Journal of Obesity ENDOCRINOLOGY & METABOLISM-
CiteScore
7.50
自引率
3.00%
发文量
19
审稿时长
21 weeks
期刊介绍: Journal of Obesity is a peer-reviewed, Open Access journal that provides a multidisciplinary forum for basic and clinical research as well as applied studies in the areas of adipocyte biology & physiology, lipid metabolism, metabolic syndrome, diabetes, paediatric obesity, genetics, behavioural epidemiology, nutrition & eating disorders, exercise & human physiology, weight control and health risks associated with obesity.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信